Search for: "E. R. Squibb " Results 21 - 40 of 71
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jun 2017, 10:42 pm by Barry Barnett
” Bristol-Meyers Squibb Co. v. [read post]
24 Sep 2017, 2:22 pm by Nancy E. Halpern, D.V.M.
McIntosh, DVM, Veterinary Medical Officer, USDA, APHIS Animal Reproducibility & Relatability of Animal Research to Human Research Panelists: Damir Hamamdzic, DVM, PhD, Research and Regulatory Affairs, Post-Approval Monitoring Compliance Administrator, Rutgers University Sarah E. [read post]
2 May 2013, 1:34 pm by Jason Rantanen
§ 271(e)(2)(A) alleging infringement of its four patents. [read post]
9 Nov 2007, 9:03 am
  The new Avandia article, "Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death", by Steven E. [read post]
20 Sep 2021, 7:34 am
  Although we conclude Amazon is a link in the vertical chain of distribution, we nevertheless recognize e-commerce may not neatly fit into a traditional sales structure. [read post]
17 Nov 2010, 1:48 am by Kelly
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Fipronil – UK:… [read post]
18 Jun 2012, 1:38 pm
The Supreme Court found that the Department of Labor’s position that pharmaceutical sales representatives were “outside salesm[e]n” exempted from the Fair Labor Standards Act was not entitled to the high deference usually afforded to agency interpretations of their own regulations under the Supreme Court precedent in Auer v. [read post]
1 Apr 2010, 3:04 am
USPTO and Myriad Genetics (Docket Report) (Peter Zura's 271 Patent Blog) (Inventive Step) (Patently-O) (Holman's Biotech IP Blog) (Patent Docs) (Ladas & Parry) (Tech Transfer Blog) (ipwars.com) (Ars Technica) (BlawgIT) (IP Watch) (The Prior Art) US: Study suggests USPTO erred in broad claims of Myriad BRCA1 patent (Tech Transfer Blog) (Patent Docs) US: CAFC confirms written description requirement in Ariad v Lilly (IP Law Blog) (IP Osgoode) (IP Spotlight) (Ars Technica) US: Justifying… [read post]
9 Dec 2009, 3:59 pm
 (Patent Docs) Loprox, Vanos (Ciclopirox) – US: Settlement announced in Loprox and Vanos patent dispute between Glenmark and Medicis (Patent Docs) Neupogen (Filgrastim) – US: E D Pennsylvania: Plaintiff seeks declaratory judgment of non-infringement and invalidity: Teva Pharmaceuticals USA, Inc. v. [read post]
28 Mar 2008, 7:25 am
The 2008 resolutions contain a clause asking for a reporting of dues paid to trade associations, defined in the proposal as "payments made to any tax exempt organization that is used for an expenditure or contribution if made directly by the corporation would not be deductible under Section 162 (e)(1)(B) of the Internal Revenue Code. [read post]
28 Apr 2011, 3:18 pm by Bexis
  Thus “[w]e do not believe comment k was intended to provide nor should it provide all ethical drugs with blanket immunity from strict liability design defect claims. [read post]
27 Feb 2009, 7:00 am
(IP ADR Blog)   Global - Trade Marks / Brands Business superbrands – Google scoops the latest poll (Class 46)   Global - Patents Innovation policy: the balance between standards and patent regulation (Intellectual Property Watch) IBM develops patent quality index tool (Competitive Info) Nichia and Seoul to end global LED patent wars (Green Patent Blog)   Global - Copyright The Commons video (Creative Commons)   Africa Egypt and Nigeria suggested for USTR… [read post]
8 Apr 2024, 10:08 am by admin
Dwyer, a young, earnest immunologist who had done some contract work on an unrelated matter for Bristol-Myers Squibb, a defendant in the litigation. [read post]